An important harmonization effort was produced by the scientific community to standardize both the preanalytical and interpretative phases of programmed death-ligand 1 (PD-L1) immunohistochemical (IHC) testing in non-small-cell lung cancer (NSCLC) [1, 2]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.